Zobrazeno 1 - 10
of 34
pro vyhledávání: ''
Reduced-Dose Prasugrel versus Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention
Publikováno v:
International Heart Journal. 62:246-255
Whether reduced-dose prasugrel has a better efficacy or safety than standard-dose clopidogrel remains unknown in patients undergoing percutaneous coronary intervention (PCI).A systematic search of PubMed, EMBASE, Google Scholar, and Cochrane Library
Publikováno v:
International Heart Journal. 62:171-174
A 41-year-old woman with chest pain for 6 hours was admitted to our chest pain center, presenting with acute myocardial infarction. Coronary angiography showed acute total occlusion in the proximal left anterior descending artery due to late stent th
Publikováno v:
International Heart Journal. 61:601-605
Giant coronary artery aneurysm (CAA) is a rare disorder, defined as coronary artery dilatation, in which the diameter of the coronary artery exceeds more than 1.5 times of its normal size. The most common cause of CAA is coronary atherosclerosis for
Publikováno v:
International Heart Journal. 60:886-898
Current studies demonstrating the effects of nicorandil in the prognosis of coronary artery disease (CAD) patients who received percutaneous coronary intervention (PCI) are inconclusive due to the small sample size and small events rate.PubMed, OVID,
Autor:
Ruri Ishibashi, Hideyuki Kawashima, Nozomu Yukimitsu, Kazuya Sasaki, Yukiko Terada, Ken Kozuma, Hiroyuki Kyono, Shintaro Takamura, Nobuaki Suzuki
Publikováno v:
International Heart Journal. 60:521-526
Prior research has revealed poorer clinical outcomes after drug-eluting stent (DES) implantation for hemodialysis patients. This study aims to investigate the long-term clinical and angiographic outcomes after new-generation DES implantation for hemo
Autor:
Ai Horiguchi, Junya Ako, Shuhei Kobayashi, Jun Kishihara, Jun Oikawa, Shinichi Niwano, Hironori Nakamura, Ryo Nishinarita, Gen Igarashi, Yuki Shirakawa, Naruya Ishizue, Hidehira Fukaya, Akira Satoh, Yuki Arakawa
Publikováno v:
International heart journal. 60(6)
Optimal antithrombotic strategy for atrial fibrillation (AF) patients with a history of percutaneous coronary intervention (PCI) has been under debate. The actual prescription trend of antithrombotic therapy for these patients remains unclear, especi
Autor:
Kui Hong, Wengen Zhu
Publikováno v:
International Heart Journal. 58:163-166
Proton pump inhibitors (PPIs) are the most effective gastric acid-suppressing agents and the mainstay medical therapy for a series of acid peptic diseases. In general, the safety profile of PPIs is excellent. However, with long-term drug administrati
Publikováno v:
International heart journal. 60(1)
The initiation and progression of atherosclerotic cardiovascular disease (ASCVD) has always been associated with a series of risk factors. Evidences of statin therapy from randomized clinical trials are abundant, whereas discussions regarding patient
Publikováno v:
International Heart Journal. 57:158-166
The clinical and angiographic outcomes after percutaneous coronary intervention (PCI) with everolimus-eluting stent (EES) implantation in patients with a history of coronary artery bypass grafting (CABG) have yet to be fully investigated. The aim of
Autor:
Manabu Ogita, Hiroshi Tamura, Ryo Naito, Tadashi Miyazaki, Hiroyuki Daida, Takatoshi Kasai, Yoshiteru Katoh, Tomotaka Dohi, Takeshi Kurata, Katsumi Miyauchi, Hirokazu Konishi, Ken Yokoyama, Iwao Okai, Shinya Okazaki, Kikuo Isoda, Shuta Tsuboi
Publikováno v:
International Heart Journal. 57:150-157
Few studies have investigated the clinical outcomes of rotational atherectomy (RA) prior to and during the drugeluting stent (DES) era. The goal of this study was to assess the long-term outcome after RA followed by DES and bare metal stent (BMS) imp